METHOD FOR MICROCYST PREVENTION IN PATIENTS WITH CYSTIC TUBERCULOSIS Russian patent published in 2009 - IPC A61K31/43 A61K31/245 A61K31/496 A61P31/06 

FIELD: medicine.

SUBSTANCE: invention concerns medicine, particularly phthisiourology and covers prevention of development of microcystitis in patients suffering from cystic tuberculosis. It is ensured by introduction of isoniasid by indirect lymphotropic technique through forming a local lymphostasis. Rifampicin is introduced in microclyster as a component of the medicinal cocktail containing Novocaine 0.5% 50 ml + Rifampicin 0.6 g + dimexid 5 ml. In addition, spasmex is prescribed in a dose 15 mg twice a day within 3 months.

EFFECT: providing good tolerance, the method enables stable relief of dysuria, increase of bladder capacity and effective prevention of apparent microcyst.

2 dwg, 2 tbl, 1 ex